MiR-122 Inhibits Cell Proliferation and Tumorigenesis of Breast Cancer by Targeting IGF1R

por Wang, Biyun, Wang, Hong, Yang, Ziang
Publicado 2012

A risk stratification model for predicting brain metastasis and brain screening benefit in patients with metastatic triple‐negative breast cancer

por Lin, Mingxi, Jin, Yizi, Jin, Jia, Wang, Biyun, Hu, Xichun, Zhang, Jian
Publicado 2020

Phase 1b clinical trial of pucotenlimab (HX008), a novel anti-PD-1 monoclonal antibody, combined with gemcitabine and cisplatin in the first-line treatment of metastatic triple-neg...

por Cao, Jun, Wang, Biyun, Zhang, Jian, Tao, Zhonghua, Wang, Leiping, Hu, Xichun
Publicado 2022

Clinicopathological characteristics, evolution, treatment pattern and outcomes of hormone-receptor-positive/HER2-low metastatic breast cancer

por You, Shuhui, Gong, Chengcheng, Li, Yi, Xie, Yizhao, Li, Yumeng, Zhao, Yannan, Wang, Biyun
Publicado 2023

Efficacy and safety of everolimus in Chinese metastatic HR positive, HER2 negative breast cancer patients: a real-world retrospective study

por Gong, Chengcheng, Zhao, Yannan, Wang, Biyun, Hu, Xichun, Wang, Zhonghua, Zhang, Jian, Zhang, Sheng
Publicado 2017

Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis

por Xie, Yizhao, Wang, Biyun, Zhao, Yannan, Tao, Zhonghua, Wang, Ye, Chen, Guangliang, Hu, Xichun
Publicado 2022

Evaluation of tumour heterogeneity by (18)F-fluoroestradiol PET as a predictive measure in breast cancer patients receiving palbociclib combined with endocrine treatment

por Liu, Cheng, Hu, Shihui, Xu, Xiaoping, Zhang, Yongping, Wang, Biyun, Song, Shaoli, Yang, Zhongyi
Publicado 2022

The role played by ailanthone in inhibiting bone metastasis of breast cancer by regulating tumor-bone microenvironment through the RANKL-dependent pathway

por Wang, Yajun, Zhong, Zeyuan, Ma, Miao, Zhao, Yannan, Zhang, Chongjing, Qian, Zhi, Wang, Biyun
Publicado 2023

The Roles of transformer-2 (tra-2) in the Sex Determination and Fertility of Riptortus pedestris, a Hemimetabolous Agricultural Pest

por Ying, Jinjun, Wang, Haiqiang, Wang, Biyun, Mao, Zeping, Chen, Youyuan, Li, Junmin, Zhang, Chuanxi, Zhuo, Jichong
Publicado 2023

GSTT1, GSTP1, and GSTM1 genetic variants are associated with survival in previously untreated metastatic breast cancer

por Zhang, Jian, Wu, Ying, Hu, Xichun, Wang, Biyun, Wang, Leiping, Zhang, Sheng, Cao, Jun, Wang, Zhonghua
Publicado 2017

An explorative analysis of the prognostic value of lactate dehydrogenase for survival and the chemotherapeutic response in patients with advanced triple-negative breast cancer

por Jia, Zhenya, Zhang, Jian, Wang, Zhonghua, Wang, Biyun, Wang, Leiping, Cao, Jun, Tao, Zhonghua, Hu, Xichun
Publicado 2018

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer

por Jin, Jia, Gao, Yu, Zhang, Jian, Wang, Leiping, Wang, Biyun, Cao, Jun, Shao, Zhimin, Wang, Zhonghua
Publicado 2018

Real‐world data of lapatinib and treatment after lapatinib in patients with previously treated HER2‐positive metastatic breast cancer: A multicenter, retrospective study

por Xie, Yizhao, Ge, Rui, Sang, Die, Luo, Ting, Li, Wei, Ji, Xuening, Yuan, Peng, Wang, Biyun
Publicado 2020

Clinical Outcomes of 130 Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Palbociclib plus Endocr...

por Liu, Chang, Li, Ting, Tao, Zhonghua, Cao, Jun, Wang, Leiping, Zhang, Jian, Wang, Biyun, Hu, Xichun
Publicado 2020

Pretreatment (18)F‐FDG uptake heterogeneity may predict treatment outcome of combined Trastuzumab and Pertuzumab therapy in patients with metastatic HER2 positive breast cancer

por Ma, Guang, You, Shuhui, Xie, Yizhao, Gu, Bingxin, Liu, Cheng, Hu, Xichun, Song, Shaoli, wang, Biyun, Yang, Zhongyi
Publicado 2023

Prognostic and predictive value of clinical and biochemical factors in breast cancer patients with bone metastases receiving "metronomic" zoledronic acid

por Zhao, Xinmin, Xu, Xiaofeng, Zhang, Qunling, Jia, Zhen, Sun, Si, Zhang, Jian, Wang, Biyun, Wang, Zhonghua, Hu, Xichun
Publicado 2011

Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L

por Liu, Rujiao, Cao, Jun, Gao, Xiang, Zhang, Jian, Wang, Leiping, Wang, Biyun, Guo, Lin, Hu, Xichun, Wang, Zhonghua
Publicado 2016

Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple-negative metastatic breast cancer

por Zhang, Jian, Wang, Leiping, Wang, Zhonghua, Wang, Biyun, Cao, Jun, Lv, Fangfang, Zhang, Sheng, Shao, Zhimin, Hu, Xichun
Publicado 2017

Prognostic Value of Tumor Heterogeneity on 18F-FDG PET/CT in HR+HER2− Metastatic Breast Cancer Patients receiving 500 mg Fulvestrant: a retrospective study

por Zhao, Yannan, Liu, Cheng, Zhang, Yingjian, Gong, Chengcheng, Li, Yi, Xie, Yizhao, Wu, Bingrui, Yang, Zhongyi, Wang, Biyun
Publicado 2018

Pyrotinib Combined With Vinorelbine in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study

por Li, Yi, Qiu, Yixuan, Li, Huihui, Luo, Ting, Li, Wei, Wang, Hong, Shao, Bin, Wang, Biyun, Ge, Rui
Publicado 2021